Express Scripts Statement on Administration's Comments on Drug Pricing

ST. LOUIS, May 11, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) released the following statement in response to the Administration's announcement today on prescription drug costs: "President Trump rightly recognizes drug companies charge way too much, and their prices need to...